Aug 6, 2026 05:05PM
Aug 6, 2026 04:05PM
Jul 28, 2026 08:31AM
Jul 28, 2026 08:30AM
Jul 16, 2026 07:05AM
Jun 29, 2026 07:02AM
Jun 29, 2026 07:00AM Relmada Therapeutics Joins Russell 2000® and Russell 3000® Indexes
Jun 11, 2026 07:02AM
Jun 11, 2026 07:00AM
May 12, 2026 04:08PM
May 12, 2026 04:05PM
May 6, 2026 07:00AM
May 5, 2026 07:00AM
Mar 19, 2026 04:10PM Relmada Therapeutics (RLMD) Misses Q4 EPS by 10c
Mar 19, 2026 04:01PM
Mar 12, 2026 07:00AM
Mar 9, 2026 07:01AM
Mar 9, 2026 07:00AM
Jan 12, 2026 07:02AM
Jan 12, 2026 07:00AM
Dec 3, 2025 07:30AM Relmada presents NDV-01 bladder cancer data at urologic meeting
Dec 3, 2025 07:30AM
Nov 13, 2025 04:31PM
Nov 13, 2025 04:01PM
Nov 7, 2025 07:30AM
Aug 7, 2025 04:22PM
Aug 7, 2025 04:05PM
Jul 31, 2025 07:00AM Relmada Therapeutics to Report Second Quarter 2025 Financial Results on Thursday, August 7, 2025
May 12, 2025 04:04PM
May 12, 2025 04:01PM
May 8, 2025 07:30AM
Mar 27, 2025 04:05PM
Mar 26, 2025 09:00AM
Nov 7, 2024 04:34PM
Nov 7, 2024 04:10PM Relmada Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
Nov 4, 2024 04:30PM
Aug 7, 2024 04:22PM
Aug 7, 2024 04:05PM
Aug 5, 2024 07:30AM
May 9, 2024 05:27PM
May 8, 2024 04:05PM
May 6, 2024 07:30AM Relmada Therapeutics to Report First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 8, 2024
Mar 19, 2024 04:24PM
Mar 19, 2024 04:15PM
Mar 12, 2024 07:30AM
Nov 8, 2023 04:30PM
Nov 8, 2023 04:30PM
Nov 8, 2023 04:01PM
Nov 3, 2023 07:30AM Relmada Therapeutics to Report Third Quarter 2023 Financial Results and Host Conference Call and Webcast on November 8, 2023
Aug 11, 2023 09:00PM

1,219,278 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All